original ) (raw )New approaches to treatment of various cancers based on cytotoxic analogs of LHRH, somatostatin and bombesin
Attila Nagy
Life Sciences, 2003
View PDFchevron_right
Therapy of ovarian cancers with targeted cytotoxic analogs of bombesin, somatostatin, and luteinizing hormone-releasing hormone and their combinations
F. Koester , Stefan Buchholz
Proceedings of the National Academy of Sciences, 2006
View PDFchevron_right
Targeted cytotoxic analogue of somatostatin AN-238 inhibits growth of androgen-independent Dunning R-3327-AT-1 prostate cancer in rats at nontoxic doses
Artur Plonowski
Cancer research, 1998
View PDFchevron_right
Inhibition of metastatic renal cell carcinomas expressing somatostatin receptors by a targeted cytotoxic analogue of somatostatin AN-238
Andrew Schally
Cancer research, 2000
View PDFchevron_right
Somatostatin Receptor-Binding Peptides Suitable for Tumor Radiotherapy with Re-188 or Re-186. Chemistry and Initial Biological Studies
Carol Nelson
Journal of Medicinal Chemistry, 2007
View PDFchevron_right
Inhibition of PC-3 human androgen-independent prostate cancer and its metastases by cytotoxic somatostatin analogue AN-238
Artur Plonowski
Cancer research, 1999
View PDFchevron_right
Targeted cytotoxic analog of luteinizing hormone–releasing hormone AN-207 inhibits growth of OV-1063 human epithelial ovarian cancers in nude mice☆☆☆★
Andrew Schally , N. Block
American Journal of Obstetrics and Gynecology, 1999
View PDFchevron_right
Preclinical study of a new 177Lu-labeled somatostatin receptor antagonist in HT-29 human colorectal cancer cells
Malihe Ramezani
DOAJ (DOAJ: Directory of Open Access Journals), 2020
View PDFchevron_right
Potent induction of apoptosis in human hepatoma cell lines by targeted cytotoxic somatostatin analogue AN-238
Malika Lasfer
Journal of Hepatology, 2005
View PDFchevron_right
Targeting of cytotoxic somatostatin analog AN-238 to somatostatin receptor subtypes 5 and/or 3 in experimental pancreatic cancers
G. Halmos
2001
View PDFchevron_right
Tumour uptake of the radiolabelled somatostatin analogue [DOTA 0 ,TYR 3 ]octreotide is dependent on the peptide amount
Marion Jong
European Journal of Nuclear Medicine and Molecular Imaging, 1999
View PDFchevron_right
Comparison of the Therapeutic Response to Treatment with a 177Lu-Labeled Somatostatin Receptor Agonist and Antagonist in Preclinical Models
D. Van Gent
Journal of Nuclear Medicine, 2015
View PDFchevron_right
Inhomogeneous activity distribution of 177Lu-DOTA0-Tyr3-octreotate and effects on somatostatin receptor expression in human carcinoid GOT1 tumors in nude mice
Eva B Forssell-Aronsson
Tumor Biology, 2012
View PDFchevron_right
Advantages and Limits of Targeted Radionuclide Therapy with Somatostatin Antagonists
Clément Morgat
Journal of Nuclear Medicine
View PDFchevron_right
Design, preparation and biological evaluation of a 177Lu-labeled somatostatin receptor antagonist for targeted therapy of neuroendocrine tumors
Malihe Ramezani
Bioorganic Chemistry, 2020
View PDFchevron_right
Multimodal Somatostatin Receptor Theranostics Using [64Cu]Cu-/[177Lu]Lu-DOTA-(Tyr3)octreotate and AN-238 in a Mouse Pheochromocytoma Model
Ralf Bergmann
Theranostics, 2016
View PDFchevron_right
Inhibition of in vivo proliferation of MDA-PCa-2b human prostate cancer by a targeted cytotoxic analog of luteinizing hormone-releasing hormone AN-207
Artur Plonowski
Cancer Letters, 2002
View PDFchevron_right
Induction of apoptosis with hybrids of Arg-Gly-Asp molecules and peptides and antimitotic effects of hybrids of cytostatic drugs and peptides
Astrid Capello
Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2005
View PDFchevron_right
Anticancer activity of modified somatostatin analogs
Astrid Capello
Annals of Neurology, 2005
View PDFchevron_right
Overview of Results of Peptide Receptor Radionuclide Therapy with 3 Radiolabeled Somatostatin Analogs
Helmut Maecke
Journal of Nuclear Medicine Official Publication Society of Nuclear Medicine, 2005
View PDFchevron_right
Targeted Chemotherapy Using a Cytotoxic Somatostatin Conjugate to Inhibit Tumor Growth and Metastasis in Nude Mice
Lichun Sun
Clinical medicine. Oncology, 2008
View PDFchevron_right
Receptors for Luteinizing Hormone Releasing Hormone Expressed on Human Renal Cell Carcinomas Can Be Used for Targeted Chemotherapy with Cytotoxic Luteinizing Hormone Releasing Hormone Analogues
Matyas Fekete
View PDFchevron_right
Receptor-mediated tumor targeting with radiolabeled peptides: there is more to it than somatostatin analogs
Alberto Signore
Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2006
View PDFchevron_right
The antitumour effect of the somatostatin analogue TT-232 depends on the treatment regimen
Miguel Tejeda
Cancer Detection and Prevention, 2003
View PDFchevron_right
Design, Synthesis, and Biological Evaluation of Somatostatin-Based Radiopeptides
Helmut Maecke
Chemistry & Biology, 2006
View PDFchevron_right
Preclinical evaluation of somatostatin analogs bearing two macrocyclic chelators for high specific activity labeling with radiometals
Helmut Maecke
Radiochimica Acta, 2007
View PDFchevron_right
Effective treatment of experimental human endometrial cancers with targeted cytotoxic luteinizing hormone–releasing hormone analogues AN-152 and AN-207
Attila Nagy
Fertility and Sterility, 2005
View PDFchevron_right
Peptide Receptor Radionuclide Therapy with radiolabelled somatostatin analogues in patients with somatostatin receptor positive tumours
Marion Jong , Roelf Valkema
Acta Oncologica, 2007
View PDFchevron_right
Regulation of targeted chemotherapy with cytotoxic lutenizing hormone-releasing hormone analogue by epidermal growth factor
Haridas Pudavar
Cancer research, 2000
View PDFchevron_right
Receptor-mediated tumor targeting based on peptide hormones
Gábor Mezo
Expert Opinion on Drug Delivery, 2009
View PDFchevron_right
Practical dosimetry of peptide receptor radionuclide therapy with (90)Y-labeled somatostatin analogs
stephan walrand
Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2005
View PDFchevron_right